1 hr 7 min

#316 Biotech Innovations Transforming Cancer Diagnosis, with Guido Baechler The Healthtech Podcast

    • Entrepreneurship

This week, James is joined by Dr Guido Baechler, CEO and Director at Mainz Biomed, a leading developer of market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection test for colorectal cancer.
Guido has 30 years of global experience leading public & private life science companies, having held senior executive roles at Singulex and SummerBio, and at Roche, where he led Roche Molecular’s global program management.

This week, James is joined by Dr Guido Baechler, CEO and Director at Mainz Biomed, a leading developer of market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection test for colorectal cancer.
Guido has 30 years of global experience leading public & private life science companies, having held senior executive roles at Singulex and SummerBio, and at Roche, where he led Roche Molecular’s global program management.

1 hr 7 min